AstraZeneca partners with Qure.ai to improve early stage diagnosis of lung cancer and reduce mortality rate in Latin America, Asia and Middle East & Africa regions
The number of COVID-19 cases in India is on the rise. Technology will play a key role as an immediate & long-term solution in handling this pandemic. Triaging, Prioritizing & managing resources - AI can assist health workers with actionable insights.
“Clinicians around the world are looking for tools to aid critical decisions around COVID-19 cases — decisions like when a patient should be admitted to the hospital, or be moved to the ICU, or be intubated,” said Chiranjiv Singh, chief commercial officer of Qure.ai. “Those clinical decisions are better made when they have objective data. And that’s what our AI tools can provide.
The platform consists of two main systems – the is a medical test program (qScout) developed by “Qure.ai” and Al Borkan Company to register individuals and follow up the development of their medical condition on a daily basis.
Qure.ai’s AI-backed solution interprets X-rays to help doctors classify patients as high-, medium- or low-risk and prioritise testing accordingly
We had a great RSNA 2018, with 4 scientific presentations, interesting conversations at our booth in the machine learning showcase, and demos at our partners’ booths.
Qure.ai won the AI Game changer award at the 6th NASSCOM Big Data & Analytics Summit on 11th July 2018. The award aimed to recognize & showcase the most innovative, high impact and high-tech AI solutions. Qure.ai’s qER solution is selected among the 273 case studies submitted by 163 companies.
Qure.ai will be at SIIM 2018. Come by the start-up showcase (booth #113) to learn more about our products and research, or get a live demo
We have 6 scientific presentations at the ECR this year - in the ‘Deep Learning’, ‘Artificial intelligence in chest imaging’, and ‘Deep learning and Radiomics’ sessions. We will also be showcasing our new Chest X-ray and Head CT product demos.
We will be exhibiting at Booth #8564, Machine Learning showcase. To learn more about Qure’s research, you can also attend these scientific presentations:
Qure.ai will be demonstrating the chest X-ray tuberculosis screening solution at the 48th Union Lung Health Conference in Guadalajara. Come see us at the Tech Innovation zone to learn more. The annual Union Lung Health conference is a four-day scientific programme and a vital meeting place for all those working on every aspect of lung health, including TB. It will unite researchers, global advocates, civil society, scientists, healthcare professionals and students working on all aspects of lung health, under the theme ‘Accelerating Toward Elimination’.
Qure.ai was named one of the TECH30 2017 - India’s most promising technology startups. The TECH30 are a coveted list of 30, announced every year the TechSparks event in Bangalore, India’s oldest and biggest tech startup summit. The winners are chosen from amongst thousands of applications. Startups from Artificial Intelligence (AI), healthtech, cyber security, and cryptocurrency made it to the list this year.
Qure.ai will be part of ‘start-up street’ at SIIM 2017, where we will demonstrate our deep learing solutions for radiology. Meet us at booth 112. The SIIM 2017 conference is the annual meeting of the society for Imaging Informatics in Medicine, bringing together innovators, thought leaders and researchers in medical imaging technology from around the world. The start-up street section is dedicated to exciting and innovative companies who will shape the future of medical imaging.
At GTC 2017, we displayed our automated reporting and quantification solutions for X-rays, CT scans and MRIs through interactive demos. It was great to see all the interest in AI in medical imaging, and great meeting everyone who stopped by our booth. The GTC showcases the most innovative work in the computing industry today—including artificial intelligence and deep learning, virtual reality, self-driving cars, and accelerated analytics.
Qure.ai is one of ten 2017 Netexplo award winners, selected from nearly 2,000 global technology initiatives. We received the award at the 10th annual Netexplo forum on April 27, 2017 at UNESCO House in Paris. “Every year Netexplo awards 10 of the most promising digital initiatives globally, selected for their innovative use of technology and potential social impact. Qure.ai is an innovation that deserves to be showcased – an Indian company, pioneering the use of AI in a way that is likely to create far-reaching impact for healthcare.”, said Marcus Goddard, Partner, Intelligence at Netexplo.
Qure.ai won the Social Innovation Award at the Emerging Companies Summit (ECS), held ahead of the first India edition of the Nvidia GPU Tech Conf, in Mumbai on 5th and 6th December 2016. With ECS, NVIDIA aims to recognize startups that are doing remarkable work in the areas of artificial intelligence, virtual reality, autonomous vehicles and robotics. Qure.ai was one of 12 emerging companies using GPU technology, selected to present at the event, and went on to win the social innovation prize, worth $200,000. The award reinforces Qure’s mission to make healthcare accessible and affordable using deep learning.
Qure.ai won the Segmentation of Cell Nuclei digital pathology challenge at MICCAI 2016. It involved nuclei segmentation in whole slide tissue images obtained from patients with non small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC), glioblastoma multiforme (GBM), and lower grade glioma. Qure.ai presented the work at MICCAI conference held at Athens